Methadone Mortality - A Reassessment |
Agenda |
8:30 - 8:40 a.m
Welcome and Acknowledgements
Kenneth Hoffman, M.D., M.P.H. (DPT/CSAT/SAMHSA) |
8:40 - 9:00 a.m.
Opening Remarks and Charge tot he Conferees
H.Westley Clark, M.D., J.D., M.P.H., CAS, FASAM; Director
Center for Substance Abuse Treatment, SAMHSA |
9:00 – 10:00 a.m.
Review of Current Information and Trends
Moderator: Moira O’Brien, M.Phil
|
DEA: ARCOS Data
Gretchen Feussner, Ph.D., DEA
|
| PowerPoint (781 KB) |
FDA: Methadone Utilization Data
Laura Governale, Pharm.D., M.B.A..
|
| PowerPoint (904 KB) |
CDC: Data from the National Center for Health Statistics
Lois Fingerhut, M.A.
|
| PowerPoint (326 KB) |
SAMHSA: Drug Abuse Warning Network (DAWN)
Elizabeth H. Crane, Ph.D., M.P.H.
|
10:00 – 10:15 a.m.
Break
|
10:15 – 11:30 a.m.
Review of Current Information and Trends (continued)
Moderator: Frank Vocci, Ph.D .
|
RADARS Methadone Study
Richard Dart, M.D., Ph.D.
|
| PowerPoint (931 KB) |
Methadone-Related Deaths in New England
Marci Sorg, Ph.D. |
Methadone-Related Deaths in Texas
Jane C.Maxwell, Ph.D. |
| PowerPoint (134 KB) |
Methadone-Related Deaths in West Virginia
Martha J. Wunsch, M..D., FAAP |
| PowerPoint (457 KB) |
Methadone-Related Deaths in Florida
Bruce Goldberger, Ph.D., DABFT |
| PowerPoint (407 KB) |
11:30 – 12:15 p.m.
Emerging Clinical Concerns
Moderator: Seddon R. Savage, M.S., M.D. |
Considerations in the Use of Methadone to Treat Addiction
Judith Martin, M.D. |
| PowerPoint (385 KB) |
Considerations in the Use of Methadone to Treat Pain
Howard A. Heit, M.D., FACP, FASAM |
A Framework for Conceptualizing Diversion of Prescription Drugs
Aaron Gilson, Ph.D. |
12:15 – 1:30 p.m.
Lunch (on your own) |
1:30 - 3:00 p.m.
Breakout Groups Meet |
Group 1: Improving Case Definitions and Classifications
Co-Chairs: Bruce Goldberger, Ph.D., DABFT and Marci Sorg, Ph.D. |
Group 2: Improving Data Collection and Analysis
Co-Chairs: Jane C. Maxwell, Ph.D., and Nina Shah, M.S.. |
Group 3: Strategies for Reducing Methadone Deaths Associated with
Addiction Treatment
Co-Chairs: Mark Parrino, M.P.A. and Joan Zweben, Ph.D. |
Group 4: Strategies for Reducing Methadone Deaths Associated with Pain Treatment
Co-Chairs: Margaret Kotz, D.O. and Howard A. Heit, M.D., FASAM |
Group 5: Medical Complications Associated with Methadone Use
Co-Chairs: Stephen Cantrill, M.D., FACEP, and Mori J. Krantz, M.D. |
Group 6: The Role of Regulatory and Law Enforcement Agencies
Co-Chairs: William Harp, M.D., and Charles Cichon |
3:00 – 3:15 p.m.
Break |
3:15 – 4:15 p.m.
Reports from the Breakout Groups
Moderator: Kenneth Hoffman, M.D., M.P.H. |
4:15 – 5:00 p.m.
Discussion and Action Planning:Do the data show an increase in methadone-
associated deaths? What factors are involved? What can be done about the problem?
Presiding: H. Westley Clark, M.D., J.D., M.P.H., CAS, FASAM |
5:00 p.m.
Meeting Adjourns |
